etoposide has been researched along with Benign Cerebellar Neoplasms in 83 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (32.53) | 18.2507 |
2000's | 29 (34.94) | 29.6817 |
2010's | 22 (26.51) | 24.3611 |
2020's | 5 (6.02) | 2.80 |
Authors | Studies |
---|---|
Dunkel, IJ; Ellison, DW; Ermoian, R; Fouladi, M; Geyer, JR; Goldman, S; Hadley, J; Huang, J; Kilburn, L; Kocak, M; Leary, SES; MacDonald, TJ; Northcott, PA; Olson, JM; Onar-Thomas, A; Phillips, P; Smith, KS; Young Poussaint, T | 1 |
Hara, J; Okada, K; Sakamoto, H; Soejima, T; Yamasaki, K | 1 |
Erdreich-Epstein, A; Mahdi, MY; Pathania, AS; Ren, X; Shackleford, GM | 1 |
Gunturu, KS; Ho, D; Raibagkar, P; Srinivasan, J | 1 |
Hara, J; Hirato, J; Okada, K; Sakamoto, H; Soejima, T | 1 |
Bartolini, S; Brandes, AA; Franceschi, E; Mascarin, M; Minichillo, S; Mura, A; Tomasello, C; Tosoni, A | 1 |
Anurathapan, U; Dhanachai, M; Hansasuta, A; Hongeng, S; Jinawath, A; Khongkhatithum, C; Mahachoklertwattana, P; Pakakasama, S; Sirachainan, N | 1 |
Andión, M; Lassaletta, A; Lavarino, C; López-Pino, MA; Madero, L; Perez-Somarriba, M | 1 |
Cowman, S; Fan, YN; Pizer, B; Sée, V | 1 |
Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E | 1 |
Clement, J; Drabick, JJ; Frauenhoffer, E; Rybka, W; Varlotto, J | 1 |
Barnes, P; Burger, P; Chen, Z; Friedman, H; Kun, L; Polkinghorn, WR; Tarbell, NJ; Yock, T; Zhou, T | 1 |
Garami, M; Hauser, P; Pócza, T; Schuler, D; Vancsó, I | 1 |
Booth, L; Conley, A; Cruickshanks, N; Dent, P; Grant, S; Kukreja, RC; Malkin, M; Poklepovic, A; Roberts, JL | 1 |
Kawaguchi, H; Kobayashi, M; Kurisu, K; Nosaka, R; Sugiyama, K; Takayasu, T; Yamasaki, F | 1 |
Abrari, A; Gupta, A; Kumar, A; Patir, R; Vaishya, S | 1 |
Craveiro, RB; Dilloo, D; Ehrhardt, M; Goetz, B; Olschewski, M; Pietsch, T; Velz, J | 1 |
Chen, SH; Jaing, TH; Lin, KL; Liu, LY; Lui, TN; Tseng, CK | 1 |
Acerno, S; Biassoni, V; Casanova, M; Cefalo, G; Collini, P; Ferrari, A; Fossati-Bellani, F; Gandola, L; Luksch, R; Mariani, L; Massimino, M; Meazza, C; Modena, P; Pecori, E; Pignoli, E; Podda, M; Poggi, G; Polastri, D; Potepan, P; Ravagnani, F; Simonetti, F; Solero, CN; Spreafico, F; Terenziani, M | 1 |
Kim, KJ; Kim, YD; Lee, YH | 1 |
Berretta, S; Biassoni, V; Cefalo, G; Collini, P; Favre, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Pecori, E; Pignoli, E; Poggi, G; Pollo, B; Riva, D; Sardi, I; Solero, C; Spreafico, F; Terenziani, M | 1 |
Allen, J; Chan, KW; Donahue, B; Holmes, E; Jakacki, R; Mehta, M; Miller, DC; Muraszko, K; Prados, M; Puccetti, D; Robertson, P; Rorke, LB; Sposto, R; Vezina, G | 1 |
Broaddus, WC; Fillmore, HL; Kadian, R; Kumar, A; Tye, GW; Van Meter, TE | 1 |
Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Shi, W | 1 |
Attinà, G; Bertolini, P; Colosimo, C; Lazzareschi, I; Mastrangelo, S; Maurizi, P; Migliorati, R; Pastore, M; Riccardi, R; Rizzo, D; Ruggiero, A | 1 |
Anson, J; Gollard, RP; Khoury, J; Mason, J; Rosen, L | 1 |
McDowell, H; Meley, D; Pizer, B; Sée, V; Spiller, DG; White, MR | 1 |
Benesch, M; Deinlein, F; Faldum, A; Fleischhack, G; Gerber, NU; Kortmann, RD; Krauss, J; Kuehl, J; Pietsch, T; Rutkowski, S; von Bueren, AO; von Hoff, K; Warmuth-Metz, M; Zwiener, I | 1 |
Botturi, A; Dimeco, F; Erbetta, A; Fariselli, L; Ferroli, P; Franzini, A; Gaviani, P; Lamperti, E; Milanesi, I; Pollo, B; Salmaggi, A; Silvani, A | 1 |
Clifford, SC; Coyle, B; Grundy, R; Levesley, J; Lindsey, JC; Lusher, ME | 1 |
Kivivuori, SM; Nygaard, R | 1 |
Escalon, E; Melnick, SJ; Nair, SM; Ramachandran, C | 1 |
Joung, YS; Kim, JH; Koo, HH; Lee, SH; Lim, DH; Shin, HJ; Son, MH; Suh, YL; Sung, KW; Yoo, KH | 1 |
Bailey, CC; Ellison, D; Gilbertson, R; Imeson, J; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, K; Tait, DM; Taylor, RE; Walker, DA; Weston, CL | 1 |
McLean, TW | 1 |
Bailey, CC; Ellison, D; Gilbertson, R; Ironside, J; Lashford, LS; Lucraft, H; Pizer, BL; Robinson, KJ; Saran, F; Tait, DM; Taylor, RE; Walker, DA; Weston, CL | 1 |
Kawaguchi, T; Kumabe, T; Tominaga, T; Watanabe, M | 1 |
Chi, SN; Finlay, JL; Gardner, SL; Knopp, EA; Levy, AS; Miller, DC; Weiner, HL; Wisoff, JH | 1 |
Bode, U; Deinlein, F; Emser, A; Graf, N; Kortmann, RD; Kuehl, J; Ottensmeier, H; Pietsch, T; Rutkowski, S; Soerensen, N; Warmuth-Metz, M; Wolff, JE | 1 |
Mori, H; Nishiyama, K; Takahashi, H; Tanaka, R; Umezu, H; Yoshimura, J | 1 |
Alcutt, D; Grogan, L; Morris, P; Nasser, Q; Razak, AR | 1 |
Chaku, J; Kellie, SJ; Lockwood, LR; O'Regan, P; Waters, KD; Wong, CK | 1 |
Babin, A; Bours, D; Carrie, C; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Neuenschwander, S; Oyharcabal-Bourden, V; Pagnier, A; Pichon, F; Ruchoux, M; Sariban, E; Vinchon, M | 1 |
Cheon, HC; Jung, S; Jung, TY; Kang, SS; Kim, IY; Kim, SH; Lee, MC; Moon, KS | 1 |
Abe, M; Imamura, J; Kida, Y; Tabuchi, K; Takagi, M; Tokumaru, S | 1 |
Alapetite, C; Bertozzi, AI; Bours, D; Bracard, S; Chastagner, P; Doz, F; Edan, C; Frappaz, D; Gentet, JC; Kalifa, C; Le Gales, C; Mosseri, V; Pagnier, A; Pichon, F; Rialland, X; Sariban, E; Tubiana, AL; Verlooy, J; Zerah, M | 1 |
Benesch, M; Berthold, F; Gnekow, AK; Kortmann, RD; Pietsch, T; Rutkowski, S; Sträter, R; Wagner, S; Warmuth-Metz, M; Wolff, JE | 1 |
Ahn, SD; Cho, EJ; Choi, ES; Ghim, TT; Koo, HH; Lim, DH; Ra, YS; Shin, HJ; Sung, KW; Yoo, KH | 1 |
Iwaki, T; Kuga, D; Matsumoto, K; Miyamoto, K; Mizoguchi, M; Niiro, H; Ohta, M; Sasaki, T; Shono, T; Suzuki, SO; Uesaka, T | 1 |
Betanzos-Cabrera, Y; Cerecedo-Díaz, F; del Angel, VW; Diegopérez-Ramírez, J; López-Aguilar, E; Rivera-Márquez, H; Sepúlveda-Vildósola, AC; Siordia-Reyes, G | 1 |
Sterling-Levis, K; White, L | 1 |
Abd-El-Aal, HH | 1 |
Hotta, T; Kawamoto, K; Kiya, K; Kurisu, K; Mikami, T; Uozumi, T | 1 |
Bouffet, E; Chastagner, P; Doz, F; Gentet, JC; Kalifa, C; Mazingue, F; Plantaz, D; Roché, H; Sariban, E; Tron, P | 1 |
Craver, RD; Gohd, RS; Hierholzer, JC; Sundin, DR | 1 |
Chang, TK; Hsien, YL; Hwang, B; Jeng, MJ; Tang, RB; Wong, TT | 1 |
Ashley, DM; Duffner, PK; Friedman, HS; Gajjar, A; Kerby, T; Kun, L; Longee, D; Meier, L; Smith, S; Zalduondo, FM | 1 |
Abe, H; Ikeda, J; Ishii, N; Kato, T; Sawamura, Y; Shirato, H; Tada, M | 1 |
Dunkel, IJ; Finlay, JL; O'Malley, B | 1 |
Asai, Y; Matsushita, K; Naitoh, T; Suetsugu, S | 1 |
Borsi, J; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D | 1 |
Leo, E; Lindemann, A; Schlegel, PG | 1 |
Chamberlain, MC | 2 |
Chamberlain, MC; Kormanik, PA | 1 |
Allen, JC; Bostrom, BC; Boyett, JM; Dunkel, IJ; Finlay, JL; Gardner, SL; Garvin, JH; Goldman, S; Li, H; Rosenblum, M; Sender, LS; Yates, A | 1 |
Morii, K; Yoshida, S | 1 |
Cardenas-Cardos, R; Castellanos-Toledo, A; Gomez-Martínez, R; Lanche-Guevara, T; Leal-Leal, C; Marx-Bracho, A; Rivera-Luna, R; Rueda-Franco, F | 1 |
Alla, P; Carloz, E; de Jauréguiberry, JP; Gisserot, O; Jaubert, D; Valance, J | 1 |
de Tribolet, N; Dietrich, PY; Pizzolato, G; Zona, G | 1 |
Baruchel, S; Chan, H; Fouladi, M; Grant, R; Greenberg, ML; Malkin, D; Weitzman, S | 1 |
Hori, S; Kawashima, H; Mori, T; Morikawa, N; Takeyama, M | 1 |
Plummer, ER; Roberts, JT | 1 |
Carapella, C; Castello, MA; Maurizi, P; Schiavetti, A; Trasimeni, G; Varrasso, G | 1 |
Bondiau, PY; Foa, C; Magné, N; Otto, J; Thyss, A | 1 |
Arai, H; Beppu, T; Hakozaki, S; Kubo, N; Ogawa, A; Suzuki, M; Wada, T; Yoshida, Y | 1 |
Alfieri, E; Cirillo, S; D'Amore, R; Fiorillo, A; Greco, N; Maggi, G; Marano, I; Martone, A; Migliorati, R | 1 |
Dhodapkar, K; Dunkel, IJ; Finlay, J; Gardner, S; Sapp, M; Thoron, L | 1 |
Kanai, H; Mabe, H; Nagai, H; Wakabayashi, S; Yamashita, N | 1 |
Hamano, S; Izawa, I; Kokunai, T; Kudo, H; Kuwamura, K; Matsumoto, S; Sawa, H; Tamaki, N; Tatsumi, S | 1 |
Itoyama, Y; Kitano, I; Kochi, M; Korematsu, K; Kuratsu, J; Seto, H; Uemura, S; Ushio, Y | 1 |
Carson, BS; Corden, BJ; Killmond, T; Kumar, AJ; Phillips, PC; Piantadosi, S; Robb, PA; Strauss, LC; Wharam, MD | 1 |
Gutjahr, P; Huber, A | 1 |
3 review(s) available for etoposide and Benign Cerebellar Neoplasms
Article | Year |
---|---|
Worsening of anti-Hu paraneoplastic neurological syndrome related to anti-PD-1 treatment: Case report and review of literature.
Topics: Antibodies, Antinuclear; Antibodies, Neoplasm; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Autoantigens; Carboplatin; Carcinoma, Small Cell; Cerebellar Neoplasms; Combined Modality Therapy; Disease Progression; ELAV Proteins; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Nivolumab; Paraneoplastic Syndromes, Nervous System; Programmed Cell Death 1 Receptor; Radiotherapy, Adjuvant; Treatment Outcome | 2020 |
Medulloblastomas and central nervous system primitive neuroectodermal tumors.
Topics: Antineoplastic Agents; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cisplatin; Cyclophosphamide; Emergency Medical Services; Etoposide; Humans; Life Style; Lomustine; Medulloblastoma; Neuroectodermal Tumors, Primitive; Neurosurgical Procedures; Radiotherapy; Self-Help Groups; Social Support; Spinal Puncture; Vincristine | 2003 |
Metastatic adult medulloblastoma showing prolonged response to chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Humans; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors; Vincristine | 1999 |
21 trial(s) available for etoposide and Benign Cerebellar Neoplasms
Article | Year |
---|---|
Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Isotretinoin; Male; Medulloblastoma; Neoplasms, Germ Cell and Embryonal; Neuroectodermal Tumors, Primitive; Prospective Studies; Vincristine; Vorinostat | 2022 |
Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Craniospinal Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Male; Medulloblastoma; Prognosis; Survival Rate; Vincristine | 2020 |
High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasm Staging; Prognosis; Risk Factors; Vincristine; Young Adult | 2013 |
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Vincristine; Young Adult | 2009 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue for patients with previously irradiated recurrent medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Neoplasm Recurrence, Local; Quality of Life; Radiotherapy; Salvage Therapy; Thiotepa; Young Adult | 2010 |
Phase I study of temozolomide combined with oral etoposide in children with recurrent or progressive medulloblastoma.
Topics: Administration, Oral; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Dacarbazine; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Medulloblastoma; Neoplasm Recurrence, Local; Temozolomide; Treatment Outcome | 2010 |
Adult medulloblastoma: multiagent chemotherapy with cisplatinum and etoposide: a single institutional experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Female; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Medulloblastoma; Middle Aged; Survival Analysis | 2012 |
Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Male; Medulloblastoma; Neoadjuvant Therapy; Radiotherapy Dosage; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; United Kingdom; Vincristine | 2003 |
Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Male; Medulloblastoma; Proportional Hazards Models; Survival Rate; Treatment Outcome; Vincristine | 2004 |
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Leucovorin; Male; Medulloblastoma; Mesna; Methotrexate; Risk Factors; Stem Cell Transplantation; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Etoposide; Follow-Up Studies; Humans; Infant; Intelligence; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Neuropsychological Tests; Postoperative Care; Proportional Hazards Models; Remission Induction; Survival Analysis; Vincristine | 2005 |
Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dementia, Vascular; Etoposide; Humans; Infant; Magnetic Resonance Imaging; Medulloblastoma; Methotrexate | 2005 |
High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Contraindications; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Infections; Kaplan-Meier Estimate; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Sepsis; Supratentorial Neoplasms; Transplantation, Autologous; Treatment Outcome; Vincristine | 2007 |
Pre-irradiation chemotherapy in high risk medulloblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Medulloblastoma; Radiotherapy; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis | 2006 |
Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP).
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Treatment Outcome | 1994 |
[In vivo effect of etoposide on the pharmacokinetics of methotrexate].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Clinical Protocols; Dose-Response Relationship, Drug; Drug Interactions; Etoposide; Humans; Medulloblastoma; Methotrexate | 1996 |
Recurrent cerebellar gliomas: salvage therapy with oral etoposide.
Topics: Adolescent; Alopecia; Antineoplastic Agents, Phytogenic; Astrocytoma; Cerebellar Neoplasms; Child; Child, Preschool; Diarrhea; Etoposide; Female; Humans; Male; Neoplasm Recurrence, Local; Salvage Therapy; Survival Analysis | 1997 |
Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Survival Analysis; Time Factors | 1997 |
Chronic oral VP-16 for recurrent medulloblastoma.
Topics: Administration, Oral; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Time Factors | 1997 |
A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Survival Analysis; Treatment Outcome | 2000 |
Cisplatin, ara-C and etoposide (PAE) in the treatment of recurrent childhood brain tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Child; Cisplatin; Cytarabine; Drug Evaluation; Ependymoma; Etoposide; Female; Glioma; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pinealoma; Probability; Prognosis | 1991 |
59 other study(ies) available for etoposide and Benign Cerebellar Neoplasms
Article | Year |
---|---|
Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Injections, Spinal; Male; Medulloblastoma; Melphalan; Methotrexate; Prognosis; Prospective Studies; Registries; Survival Rate | 2020 |
GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cerebellar Neoplasms; Cisplatin; Etoposide; G-Protein-Coupled Receptor Kinase 2; HEK293 Cells; Humans; Medulloblastoma; Phosphorylation | 2019 |
Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Medulloblastoma; Middle Aged; Neutropenia; Progression-Free Survival; Radiotherapy; Rare Diseases; Risk; Thrombocytopenia; Young Adult | 2020 |
Outcome of newly diagnosed high risk medulloblastoma treated with carboplatin, vincristine, cyclophosphamide and etoposide.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Humans; Infant; Medulloblastoma; Vincristine | 2018 |
Old drugs still work! Oral etoposide in a relapsed medulloblastoma.
Topics: Administration, Oral; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Etoposide; Humans; Male; Medulloblastoma; Neoplasm Recurrence, Local | 2019 |
Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Topics: Cell Cycle; Cell Cycle Proteins; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Medulloblastoma; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Radiation Tolerance | 2019 |
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult | 2013 |
Unusual case of recurrent extraneural metastatic medulloblastoma in a young adult: durable complete remission with Ewing sarcoma chemotherapy regimen and consolidation with autologous bone marrow transplantation and local radiation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Biopsy; Cerebellar Neoplasms; Cyclophosphamide; Dose Fractionation, Radiation; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Induction Chemotherapy; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Medulloblastoma; Multimodal Imaging; Neck; Positron-Emission Tomography; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Recurrence; Sarcoma, Ewing; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vincristine | 2013 |
[Antiangiogenic treatment of pediatric CNS tumors in Hungary with the Kieran schedule].
Topics: Administration, Oral; Adolescent; Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow; Brain Neoplasms; Brain Stem Neoplasms; Carcinoma; Celecoxib; Cerebellar Neoplasms; Child; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Ependymoma; Etoposide; Female; Humans; Hungary; Ischemic Attack, Transient; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Optic Nerve Glioma; Pyrazoles; Quality of Life; Retrospective Studies; Sulfonamides; Thalidomide; Treatment Outcome | 2013 |
PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Child; Cisplatin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Medulloblastoma; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vincristine | 2014 |
Cavernous angioma after chemotherapy for desmoplastic/nodular medulloblastoma associated with anhidrotic ectodermal dysplasia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Ectodermal Dysplasia; Etoposide; Hemangioma, Cavernous, Central Nervous System; Humans; Infant; Intracranial Hemorrhages; Male; Medulloblastoma; Melphalan; Methotrexate; Neurosurgical Procedures; Peripheral Blood Stem Cell Transplantation; Vincristine | 2016 |
Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Critical Care; Cyclophosphamide; Drug Administration Schedule; Etoposide; Histone Deacetylase Inhibitors; Humans; Infant; Longitudinal Studies; Male; Medulloblastoma; Neoadjuvant Therapy; Neurocognitive Disorders; Neurodevelopmental Disorders; Treatment Outcome; Valproic Acid; Vincristine | 2016 |
The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Humans; Indazoles; Medulloblastoma; Molecular Targeted Therapy; Phosphoinositide-3 Kinase Inhibitors; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides | 2017 |
Multivariate survival analysis of children with medulloblastoma--a single-center experience.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Male; Medulloblastoma; Multivariate Analysis; Radiation-Sensitizing Agents; Survival Analysis | 2008 |
No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Salvage Therapy; Thiotepa; Vincristine; Young Adult | 2009 |
Secondary leukemia in a child conceived using in vitro fertilization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine | 2008 |
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2009 |
The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Child; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Humans; Isoenzymes; Medulloblastoma; Phosphorylcholine; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Transfection | 2009 |
Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse.
Topics: Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Etoposide; Female; Humans; Methylprednisolone Hemisuccinate; Neuroectodermal Tumors, Primitive; Neuroprotective Agents; Radiotherapy; Spinal Neoplasms; Temozolomide; Thiotepa; Thoracic Vertebrae; Vincristine; Young Adult | 2011 |
p53-mediated delayed NF-κB activity enhances etoposide-induced cell death in medulloblastoma.
Topics: Caspases; Cell Death; Cell Line, Tumor; Cerebellar Neoplasms; Drug Screening Assays, Antitumor; Etoposide; Humans; Medulloblastoma; Models, Biological; NF-kappa B; Phosphorylation; Receptors, Death Domain; Transcription Factor RelA; Tumor Suppressor Protein p53 | 2010 |
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Magnetic Resonance Imaging; Male; Medulloblastoma; Methotrexate; Neoplasm Recurrence, Local; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Survival Rate; Vincristine | 2011 |
RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Biphenyl Compounds; Blotting, Western; Caspases; Cell Line, Tumor; Cerebellar Neoplasms; Child; Cisplatin; Etoposide; Humans; Immunoenzyme Techniques; Medulloblastoma; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tumor Suppressor Proteins | 2011 |
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapy.
Topics: Administration, Metronomic; Adolescent; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cerebellar Neoplasms; Cytarabine; Etoposide; Humans; Injections, Spinal; Liposomes; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neutropenia; Pyrazoles; Sulfonamides; Thalidomide; Treatment Outcome | 2012 |
Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Curcuma; Curcumin; Dacarbazine; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Glioblastoma; Humans; Inhibitory Concentration 50; Medulloblastoma; Phytotherapy; Plant Extracts; Plants, Medicinal; Rhizome; Temozolomide | 2012 |
Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Medulloblastoma; Melphalan; Neoplasm Staging; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Salvage Therapy; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2013 |
Atypical teratoid/rhabdoid tumour with leptomeningeal dissemination in an adult.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Disease Progression; Etoposide; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methotrexate; Neoplasm Invasiveness; Rhabdoid Tumor; Teratoma | 2004 |
[Medulloblastoma with mandibular metastasis after complete remission of the central nervous system lesions].
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Child; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Etoposide; Humans; Magnetic Resonance Imaging; Male; Mandibular Neoplasms; Medulloblastoma; Nimustine; Remission Induction | 2005 |
Medulloblastoma in two successive pregnancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Medulloblastoma; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Treatment Outcome; Vincristine | 2005 |
Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Humans; Male; Medulloblastoma; Radiotherapy Dosage; Spinal Canal; Survival Rate | 2005 |
Primary endodermal sinus tumor of the cerebellar hemisphere: a case report with review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Endodermal Sinus Tumor; Etoposide; Humans; Magnetic Resonance Imaging; Male; Neurosurgical Procedures | 2006 |
Stereotactic radiation therapy with chemotherapy in the management of recurrent medulloblastomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Ifosfamide; Male; Medulloblastoma; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Radiosurgery; Radiotherapy Dosage; Retrospective Studies | 2006 |
Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Etoposide; Humans; Medulloblastoma; Postoperative Care; Prospective Studies; Risk Factors; Treatment Outcome | 2006 |
Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Glioblastoma; Glioma; Humans; Infant; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Pons; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2006 |
Enhanced expression of DNA topoisomerase II genes in human medulloblastoma and its possible association with etoposide sensitivity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; DNA; DNA Topoisomerases, Type II; Drug Resistance, Neoplasm; Etoposide; Gene Expression; Gene Expression Profiling; Humans; Immunohistochemistry; Medulloblastoma; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2007 |
Clinical and molecular parameters for risk stratification in Mexican children with medulloblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Medulloblastoma; Mexico; Probability; Receptor, ErbB-2; Risk; Risk Assessment; Survival Rate; Time Factors | 2007 |
Multiagent chemotherapy studied in a xenograft model of medulloblastoma/primitive neuroectodermal tumour: analysis of the VETOPEC regimen.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; Cyclophosphamide; Etoposide; Humans; Medulloblastoma; Mice; Mice, Nude; Neuroectodermal Tumors, Primitive; Time Factors; Vincristine; Xenograft Model Antitumor Assays | 2008 |
In vivo effects of recombinant human lymphotoxin on human medulloblastoma xenograft: enhancement of antitumor activity of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Drug Synergism; Etoposide; Female; Humans; Indicators and Reagents; Lymphotoxin-alpha; Medulloblastoma; Mice; Mice, Inbred BALB C; Mice, Nude; Recombinant Proteins; Subrenal Capsule Assay; Tumor Necrosis Factor-alpha | 1994 |
Isolation of parainfluenza virus type 3 from cerebrospinal fluid associated with aseptic meningitis.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Female; Humans; Infant; Macaca mulatta; Male; Medulloblastoma; Meningitis, Aseptic; Parainfluenza Virus 3, Human; Vincristine | 1993 |
Preirradiation chemotherapy for very young children with brain tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Ependymoma; Etoposide; Female; Follow-Up Studies; Glioblastoma; Humans; Infant; Male; Medulloblastoma; Neurologic Examination; Vinblastine | 1993 |
Response of recurrent medulloblastoma to low-dose oral etoposide.
Topics: Administration, Oral; Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Child; Child, Preschool; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local | 1996 |
Combined irradiation and chemotherapy using ifosfamide, cisplatin, and etoposide for children with medulloblastoma/posterior fossa primitive neuroectodermal tumor--results of a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Irradiation; Disease-Free Survival; Etoposide; Female; Hearing Loss; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Male; Medulloblastoma; Neuroectodermal Tumors, Primitive; Pilot Projects; Radiotherapy, Adjuvant; Remission Induction; Skull Base Neoplasms | 1996 |
Is there a role for high-dose chemotherapy with stem cell rescue for brain stem tumors of childhood?
Topics: Adult; Astrocytoma; Cerebellar Neoplasms; Cerebellopontine Angle; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Radiotherapy; Survival Rate; Thiotepa | 1996 |
[A patient with lung metastasis of medulloblastoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Etoposide; Humans; Lung Neoplasms; Male; Medulloblastoma; Spinal Cord Neoplasms | 1996 |
Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Medulloblastoma; Methotrexate; Remission Induction; Vincristine | 1997 |
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Medulloblastoma; Neoplasm Recurrence, Local; Survival Analysis; Thiotepa; Transplantation, Autologous | 1998 |
Brain metastasis from germinal tumors of the testis. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cerebellar Neoplasms; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Radiography, Thoracic; Reoperation; Testicular Neoplasms | 1998 |
Is the ancillary chemotherapy approach of any value in the treatment of infratentorial primitive neuroectodermal tumors with surgery and radiotherapy?
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Infant; Male; Neoplasm Staging; Neuroectodermal Tumors, Primitive, Peripheral; Retrospective Studies; Survival Analysis; Treatment Outcome | 1998 |
[Meningoradiculitis revealing an occult medulloblastoma-PNET in an adult].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Meningitis; Methotrexate; Middle Aged; Neuroectodermal Tumors, Primitive; Oculomotor Nerve; Polyradiculopathy | 1998 |
Etoposide-carboplatin association as 'emergency' up-front chemotherapy in a case of life-threatening adult medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Emergencies; Etoposide; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma | 1998 |
Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas.
Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Ependymoma; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Survival Analysis | 1998 |
Pharmacokinetics of etoposide in plasma and cerebrospinal fluid in the space left by tumor removal.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma | 1999 |
Metastatic medulloblastoma in 10-year-old girl treated successfully with chemotherapy without radiotherapy.
Topics: Administration, Oral; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Medulloblastoma | 1999 |
High-dose chemotherapy with autologous stem cell support in an adult with bone marrow relapse of medulloblastoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Busulfan; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Medulloblastoma; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Thiotepa; Transplantation, Autologous | 2000 |
Shunt-related abdominal metastases in an infant with medulloblastoma: long-term remission by systemic chemotherapy and surgery.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carmustine; Cerebellar Neoplasms; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Hydrocephalus; Hydroxyurea; Infant; Liver Neoplasms; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Pelvic Neoplasms; Peritoneal Neoplasms; Remission Induction; Ventriculoperitoneal Shunt | 2001 |
Preliminary results of dose intensive pre-irradiation chemotherapy in patients older than 10 years of age with high risk medulloblastoma and supratentorial primitive neuroectodermal tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medical Records; Medulloblastoma; Neoadjuvant Therapy; Neoplasm Staging; Neuroectodermal Tumors; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Vincristine | 2002 |
[A case of extraneural metastasis of medulloblastoma successfully treated with cisplatin and etoposide].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child, Preschool; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Male; Medulloblastoma; Remission Induction; Thoracic Neoplasms | 1992 |
Treatment of early recurrent medulloblastoma in children with cisplatin and etoposide: a preliminary report.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neurologic Examination; Tomography, X-Ray Computed | 1992 |
[Combination chemotherapy with cisplatin and etoposide for cerebellar metastasis from ovarian adenocarcinoma].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Cisplatin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Remission Induction | 1991 |
Treatment of medulloblastoma.
Topics: Adolescent; Cerebellar Neoplasms; Etoposide; Humans; Male; Medulloblastoma; Remission Induction | 1990 |